Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
Clorox | 18,373 | 2024q2 | |||||||||
Lumentum Holdings | 2,813 | 2024q2 | |||||||||
American Express | 212,824 | 2023q2 | |||||||||
Under Armour | 4,957 | 2023q1 | |||||||||
ΠΠΎΡΠΎΠ΄ΡΠΊΠΈΠ΅ ΠΠ½Π½ΠΎΠ²Π°ΡΠΈΠΎΠ½Π½ΡΠ΅ Π’... | 0 | 2021q2 | |||||||||
Schweizerische Nationalba... | 387 | 2022 | |||||||||
Allakos | 121 | 2023q3 | |||||||||
Madrigal Pharmaceuticals | 3,943 | 2023q1 | |||||||||
iTeos Therapeutics | 626 | 2023q3 | |||||||||
Palo Alto Networks | 85,700 | 2023 | |||||||||
Check-Cap | 182 | 2021 | |||||||||
Gossamer Bio | 130 | 2023q1 | |||||||||
Iovance Biotherapeutics | 2,756 | 2023q1 | |||||||||
Nikola Corp. | 3,106 | 2021 | |||||||||
Xinyuan Real Estate Co | 18 | 2022q2 | |||||||||
Bellerophon Therapeutics | 0 | 2021 | |||||||||
Passage Bio | 63 | 2023q3 | |||||||||
Vaxcyte | 3,786 | 2021 | |||||||||
Oric Pharmaceuticals | 560 | 2023q3 | |||||||||
Prelude Therapeutics | 294 | 2023q2 |